Consumer Discretionary • Catalog/Specialty Distribution
$20.83 ▲ +0.19
(+0.92%)
MKT CAP: $8.37B • VOL: 7.25M
52W L $17 52W H $37
CHWY // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-01 | FY 2024
FILED 2025-02-02 | FY 2023
FILED 2024-01-28 |
|---|---|---|---|
| Revenue (Total Sales) | $12.60B | $11.86B | $11.15B |
| YoY Revenue Growth % | +6.2% | +6.4% | — |
| Gross Profit | $3.75B | $3.47B | $4.90B |
| Gross Margin % | 29.8% | 29.2% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $254.3M | $112.6M | -$23.6M |
| Operating Margin % | 2.0% | 0.9% | -0.2% |
| Net Income (GAAP) | $222.8M | $392.7M | $39.6M |
| EBITDA (Normalized) | $708.0M | $539.6M | $377.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $691.6M | $596.3M | $486.2M |
| Capital Expenditures (CapEx) | $567.1M | $533.8M | $501.6M |
| Free Cash Flow (FCF) | $124.5M | $62.5M | -$15.4M |
| FCF Margin % | 1.0% | 0.5% | -0.1% |
| Return on Invested Capital (ROIC %) | 95.0% | 9.8% | -0.2% |
| Cash & Short-Term Equivalents | $860.1M | $595.8M | $1.47B |
| Total Debt (Short + Long Term) | $0 | $1.24B | $3.13B |
| Total Stockholders' Equity | $497.9M | $261.5M | $6.42B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CHWY.